Seidah NG, Prat A. The biology and therapeutic targeting of the proprotein convertases. Nat Rev Drug Discov. 2012;11:367–83.

Article  PubMed  CAS  Google Scholar 

Mbikay M, Sirois F, Yao J, Seidah NG, Chrétien M. Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours. Br J Cancer. 1997;75:1509–14.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Nakajima T, Konda Y, Kanai M, Izumi Y, Kanda N, Nanakin A, et al. Prohormone convertase furin has a role in gastric cancer cell proliferation with parathyroid hormone-related peptide in a reciprocal manner. Dig Dis Sci. 2002;47:2729–37.

Article  PubMed  CAS  Google Scholar 

Rose M, Duhamel M, Aboulouard S, Kobeissy F, Rhun EL, Desmons A, et al. The role of a proprotein convertase inhibitor in reactivation of tumor-associated macrophages and inhibition of glioma growth. Mol Ther Oncolytics. 2020;17:31–46.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Duhamel M, Rodet F, Delhem N, Vanden Abeele F, Kobeissy F, Nataf S, et al. Molecular consequences of proprotein convertase 1/3 (PC1/3) inhibition in macrophages for application to cancer immunotherapy: a proteomic study. Mol Cell Proteom. 2015;14:2857–77.

Article  CAS  Google Scholar 

Scamuffa N, Siegfried G, Bontemps Y, Ma L, Basak A, Cherel G, et al. Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells. J Clin Invest. 2008;118:352–63.

Article  PubMed  CAS  Google Scholar 

Jaaks P, D’Alessandro V, Grob N, Büel S, Hajdin K, Schäfer BW, et al. The proprotein convertase furin contributes to rhabdomyosarcoma malignancy by promoting vascularization, migration and invasion. PLoS ONE. 2016;11: e0161396.

Article  PubMed  PubMed Central  Google Scholar 

Rousselet E, Benjannet S, Marcinkiewicz E, Asselin M-C, Lazure C, Seidah NG. Proprotein convertase PC7 enhances the activation of the EGF receptor pathway through processing of the EGF precursor. J Biol Chem. 2011;286:9185–95.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gerovska D, García-Gallastegi P, Descarpentrie J, Crende O, Casado-Andrés M, Martín A, et al. Proprotein convertases blockage up-regulates specifically metallothioneins coding genes in human colon cancer stem cells. Biochimica et Biophysica Acta (BBA) BBA Mol Cell Res. 2021;1868:118912.

Article  CAS  Google Scholar 

He Z, Khatib A-M, Creemers JWM. Loss of proprotein convertase Furin in mammary gland impairs proIGF1R and proIR processing and suppresses tumorigenesis in triple negative breast cancer. Cancers (Basel). 2020;12:2686.

Article  PubMed  CAS  Google Scholar 

Jaaks P, Bernasconi M. The proprotein convertase furin in tumour progression: the PC furin in tumour progression. Int J Cancer. 2017;141:654–63.

Article  PubMed  CAS  Google Scholar 

Zhang Y, Zhou M, Wei H, Zhou H, He J, Lu Y, et al. Furin promotes epithelial-mesenchymal transition in pancreatic cancer cells via Hippo-YAP pathway. Int J Oncol. 2017;50:1352–62.

Article  PubMed  CAS  Google Scholar 

Dongre A, Weinberg RA. New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69–84.

Article  PubMed  CAS  Google Scholar 

Harvey KF, Zhang X, Thomas DM. The hippo pathway and human cancer. Nat Rev Cancer. 2013;13:246–57.

Article  PubMed  CAS  Google Scholar 

Siegfried G, Descarpentrie J, Evrard S, Khatib A-M. Proprotein convertases: key players in inflammation-related malignancies and metastasis. Cancer Lett. 2020;473:50–61.

Article  PubMed  CAS  Google Scholar 

Seeneevassen L, Giraud J, Molina-Castro S, Sifré E, Tiffon C, Beauvoit C, et al. Leukaemia inhibitory factor (LIF) inhibits cancer stem cells tumorigenic properties through hippo kinases activation in gastric cancer. Cancers. 2020;12:2011.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tiffon C, Giraud J, Molina-Castro SE, Peru S, Seeneevassen L, Sifré E, et al. TAZ controls helicobacter pylori-induced epithelial-mesenchymal transition and cancer stem cell-like invasive and tumorigenic properties. Cells. 2020;9:1462.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Giraud J, Molina-Castro S, Seeneevassen L, Sifré E, Izotte J, Tiffon C, et al. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells. Int J Cancer. 2020;146:2255–67.

Article  PubMed  CAS  Google Scholar 

Hayakawa Y, Sakitani K, Konishi M, Asfaha S, Niikura R, Tomita H, et al. Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling. Cancer Cell. 2017;31:21–34.

Article  PubMed  CAS  Google Scholar 

Takaishi S, Okumura T, Tu S, Wang SSW, Shibata W, Vigneshwaran R, et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 2009;27:1006–20.

Article  PubMed  CAS  Google Scholar 

Nguyen PH, Giraud J, Chambonnier L, Dubus P, Wittkop L, Belleannée G, et al. Characterization of biomarkers of tumorigenic and chemoresistant cancer stem cells in human gastric carcinoma. Clin Cancer Res. 2017;23:1586–97.

Article  PubMed  CAS  Google Scholar 

Giraud J, Seeneevassen L, Rousseau B, Bouriez D, Sifré E, Giese A, et al. CD44v3 is a marker of invasive cancer stem cells driving metastasis in gastric carcinoma. Gastric Cancer. 2022. https://doi.org/10.1007/s10120-022-01357-y.

Article  PubMed  PubMed Central  Google Scholar 

Nguyen PH, Giraud J, Staedel C, Chambonnier L, Dubus P, Chevret E, et al. All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth. Oncogene. 2016;35:5619–28.

Article  PubMed  CAS  Google Scholar 

Genevois C, Hocquelet A, Mazzocco C, Rustique E, Couillaud F, Grenier N. In vivo imaging of prostate cancer tumors and metastasis using non-specific fluorescent nanoparticles in mice. Int J Mol Sci. 2017;18:2584.

Article  PubMed  PubMed Central  Google Scholar 

Visualizing and interpreting cancer genomics data via the Xena platform | Nat Biotechnol [Internet]. [cited 2023 Feb 6]. Available from: https://www.nature.com/articles/s41587-020-0546-8

Bartha Á, Győrffy B. TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci. 2021;22:2622.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Szász AM, Lánczky A, Nagy Á, Förster S, Hark K, Green JE, et al. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1065 patients. Oncotarget. 2016;7:49322–33.

Article  PubMed  PubMed Central  Google Scholar 

Posta M, Győrffy B. Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors. Clin Transl Sci. 2023;16:1479–91.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bakir B, Chiarella AM, Pitarresi JR, Rustgi AK. EMT, MET, plasticity, and tumor metastasis. Trends Cell Biol. 2020;30:764–76.

Article  PubMed  PubMed Central  Google Scholar 

Wang L, Li S, Luo H, Lu Q, Yu S. PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages. J Exp Clin Cancer Res. 2022;41:303.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Khatib A-M, (Eds). Regulation of Carcinogenesis, angiogenesis and metastasis by the proprotein convertases (PCs): A new potential strategy in cancer therapy [Internet]. Dordrecht: Springer Netherlands; 2006 [cited 2021 Oct 11]. Available from: http://link.springer.com/https://doi.org/10.1007/1-4020-5132-8

Xu B, Li S, Fang Y, Zou Y, Song D, Zhang S, et al. Proprotein convertase subtilisin/kexin type 9 promotes gastric cancer metastasis and suppresses apoptosis by facilitating MAPK signaling pathway through HSP70 up-regulation. Front Oncol. 2021;10: 609663.

Article  PubMed  PubMed Central  Google Scholar 

Klein-Szanto AJ, Bassi DE. Proprotein convertase inhibition: paralyzing the cell’s master switches. Biochem Pharmacol. 2017;140:8–15.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lapierre M, Siegfried G, Scamuffa N, Bontemps Y, Calvo F, Seidah NG, et al. Opposing function of the proprotein convertases Furin and PACE4 on breast cancer cells’ malignant phenotypes: role of tissue inhibitors of metalloproteinase-1. Cancer Res. 2007;67:9030–4.

Article  PubMed  CAS  Google Scholar 

Bessonnard S, Mesnard D, Constam DB. PC7 and the related proteases Furin and Pace4 regulate E-cadherin function during blastocyst formation. J Cell Biol. 2015;210:1185–97.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Posthaus H, Dubois CM, Laprise M-H, Grondin F, Suter MM, Müller E. Proprotein cleavage of E-cadherin by furin in baculovirus over-expression system: potential role of other convertases in mammalian cells. FEBS Lett. 1998;438:306–10.

Article